Prescient Therapeutics LimitedASX: PTX

Prescient to resume AML trial

Sep 4, 2017 at 3:02 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment